A Randomized Controlled Trial Evaluation of the Not a Number Program to Prevent the Commercial Sexual Exploitation of Children (CSEC) and Youth in Minnesota

对明尼苏达州防止儿童和青少年商业性剥削 (CSEC) 的“非数字”计划的随机对照试验评估

基本信息

  • 批准号:
    10560155
  • 负责人:
  • 金额:
    $ 32.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2027-09-29
  • 项目状态:
    未结题

项目摘要

Although the exact scope of commercial sexual exploitation of children (CSEC) remains unknown, its significant negative physical and emotional consequences for children has been well documented. However, there is little evaluation research to guide communities on prevention best practices and questions remain about what approaches can be effective. Not a Number (NAN) is a CSEC prevention education program developed by the non-profit organization Love 146. NAN is being delivered through a train-the-trainer model to groups of youth in Minnesota at-risk for CSEC. While it is a promising and evidence supported program, it has yet to be evaluated. The goal of this study is to evaluate the effectiveness of NAN in reducing rates of CSEC victimization for youth by using a rigorous cluster randomized controlled methodology in partnership with 24 youth-serving agencies in Minnesota. The research team will use a Community Based Participatory Research (CBPR) approach to implementing and understanding the evaluation. The 5-year study will be divided into two components. Component A (Study years 1-2) will involve: refining the study methodology; conducting a process evaluation of NAN implementation in Minnesota; qualitative data collection to understand community perspectives on prevention outcome goals, and pilot testing evaluation tools and methodology. Component B (Study years 3-5) will involve implementing the evaluation. Twenty-four youth serving agencies will be paired based on agency and community characteristics (e.g., agency size, community demographics, rural or urban location). Within each pair, agencies will be randomly assigned to an implementation condition (NAN administered within six months of the pre-test) or to a wait-list control condition (NAN program administered after 6-month follow-up surveys are completed by youth). Approximately 30 youth will be enrolled in the study per agency (N=720; n=360 per condition), with outcome data collected at 4 time-points: baseline, 6-week follow-up, 6-month follow-up and 12-month follow- up. The study, led by an experienced, multi-disciplinary team of researchers and practitioners, will represent the first rigorous evaluation of a CSEC prevention program. Findings will provide critical insight into the efficacy of education-based prevention for reducing CSEC victimization and inform future program development and prevention policy. This study addresses the CDC’s Research Priority 4 outlined in RFA-CE-22-003.
尽管对儿童的商业性剥削 (CSEC) 的确切范围仍然存在 未知,它对儿童的身体和情感产生显着的负面影响 有据可查。然而,很少有评估研究来指导社区 预防最佳实践和关于哪些方法可以有效的问题仍然存在。不是一个 Number (NAN) 是由非营利组织开发的 CSEC 预防教育项目 组织 Love 146. NAN 正在通过培训师培训模型向以下群体提供: 明尼苏达州的青少年面临 CSEC 风险。虽然这是一个有前途且有证据支持的计划,但它 尚未评估。本研究的目的是评估 NAN 在以下方面的有效性: 通过使用严格的整群随机控制来降低青少年 CSEC 受害率 与明尼苏达州 24 个青年服务机构合作的方法。研究团队 将使用基于社区的参与性研究(CBPR)方法来实施和 了解评价。这项为期5年的研究将分为两个部分。 A 部分(第 1-2 年学习)将涉及: 完善研究方法;进行一个 明尼苏达州实施 NAN 的过程评估;定性数据收集 了解社区对预防结果目标和试点测试评估的看法 工具和方法。 B 部分(第 3-5 年学习)将涉及实施 评估。 24家青少年服务机构将根据机构和社区进行配对 特征(例如机构规模、社区人口统计、农村或城市位置)。之内 每对机构将被随机分配到一个实施条件(NAN 在预测试后六个月内进行)或等待名单控制条件(NAN计划 由青少年完成 6 个月的跟踪调查后进行)。约30名青少年 将按机构登记参加该研究(N=720;每个条件 n=360),并提供结果数据 在 4 个时间点收集:基线、6 周随访、6 个月随访和 12 个月随访 向上。该研究由经验丰富的多学科研究人员和从业人员团队领导, 这将是对 CSEC 预防计划的首次严格评估。调查结果将提供 对基于教育的预防对于减少 CSEC 受害者的有效性的重要见解 并为未来的计划制定和预防政策提供信息。这项研究涉及疾病预防控制中心 RFA-CE-22-003 中概述了研究优先事项 4。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LISA M JONES其他文献

LISA M JONES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LISA M JONES', 18)}}的其他基金

A Randomized Controlled Trial Evaluation of the Not a Number Program to Prevent the Commercial Sexual Exploitation of Children (CSEC) and Youth in Minnesota
对明尼苏达州防止儿童和青少年商业性剥削 (CSEC) 的“非数字”计划的随机对照试验评估
  • 批准号:
    10696120
  • 财政年份:
    2022
  • 资助金额:
    $ 32.43万
  • 项目类别:

相似海外基金

A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
  • 批准号:
    23K24566
  • 财政年份:
    2024
  • 资助金额:
    $ 32.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Multimodal opioid-sparing postoperative pain protocol versus standard of care for patients undergoing knee and shoulder arthroscopy: a randomized controlled trial and knowledge translation strategy
多模式阿片类药物保留术后疼痛方案与接受膝关节和肩关节镜检查的患者的护理标准:随机对照试验和知识转化策略
  • 批准号:
    485091
  • 财政年份:
    2023
  • 资助金额:
    $ 32.43万
  • 项目类别:
    Operating Grants
Early genomic testing for inherited bleeding disorders in patients without a diagnosis after first-line testing: a randomized controlled trial
对一线检测后未确诊的患者进行遗传性出血性疾病的早期基因组检测:一项随机对照试验
  • 批准号:
    495946
  • 财政年份:
    2023
  • 资助金额:
    $ 32.43万
  • 项目类别:
    Operating Grants
Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer
对晚期癌症患者进行有针对性的早期姑息治疗 (STEP2) 进行现场和虚拟症状筛查的随机对照试验
  • 批准号:
    490098
  • 财政年份:
    2023
  • 资助金额:
    $ 32.43万
  • 项目类别:
    Operating Grants
ImproviNg rEnal outcomes following coronary angiograPhy and/or percuTaneoUs coroNary intErventions: a pragmatic, adaptive, patient-oriented randomized controlled trial
改善冠状动脉造影和/或经皮冠状动脉介入治疗后的肾脏结局:一项务实、适应性、以患者为导向的随机对照试验
  • 批准号:
    478732
  • 财政年份:
    2023
  • 资助金额:
    $ 32.43万
  • 项目类别:
    Operating Grants
Internet-based behavioral therapy program for preventing perinatal depression among fathers: a randomized controlled trial
基于互联网的行为治疗计划预防父亲围产期抑郁症:一项随机对照试验
  • 批准号:
    23K16345
  • 财政年份:
    2023
  • 资助金额:
    $ 32.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Arthroscopic-assisted tibial plateau fixation (AATPF) vs. Open reduction internal fixation (ORIF): A multicenter randomized controlled trial
关节镜辅助胫骨平台固定术 (AATPF) 与切开复位内固定术 (ORIF):一项多中心随机对照试验
  • 批准号:
    10723527
  • 财政年份:
    2023
  • 资助金额:
    $ 32.43万
  • 项目类别:
A Randomized Controlled Trial of a Diagnostic Stewardship Intervention to Reduce Inappropriate Antibiotic Use for Urinary Tract Infections in Primary Care
一项诊断管理干预措施的随机对照试验,以减少初级保健中尿路感染的不当抗生素使用
  • 批准号:
    10716759
  • 财政年份:
    2023
  • 资助金额:
    $ 32.43万
  • 项目类别:
Veggie Rx: A pilot, 3-arm randomized controlled trial of a fruit and vegetable prescription program for patients with type two diabetes
Veggie Rx:针对二型糖尿病患者的水果和蔬菜处方计划的试点、三组随机对照试验
  • 批准号:
    10735542
  • 财政年份:
    2023
  • 资助金额:
    $ 32.43万
  • 项目类别:
BOLSTER: Strengthening Patient and Caregiver Supports in Advanced Gynecologic and Gastrointestinal Cancers - a Multi-Site Randomized Controlled Trial
BOLSTER:加强晚期妇科和胃肠道癌症患者和护理人员的支持 - 一项多中心随机对照试验
  • 批准号:
    10583119
  • 财政年份:
    2023
  • 资助金额:
    $ 32.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了